Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol

A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 107 participants.

Also called NCT01362218

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 107 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01362218
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01362218. Randomized; no masking; primary purpose prevention. Start 2010-10 (registry gives no type); primary completion 2012-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol
Condition
Elevated LDL Cholesterol
Intervention (Drug)
Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril)
Intervention (Drug)
Simvastatin, ramipril, acetylsalicylic acid
Lead sponsor
Ferrer Internacional S.A. (class: industry)

Record details

Record id
cardio:ct-nct01362218
Content hash
fded7437983e9cb24c67a820fe4f2c745065cf0058c09896f50b20052ef17519